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Humphrey Center researcher leads 
efforts to prevent a deadly skin cancer 
Malignant melanoma is the fastest-growing 
of all cancers, claiming an estimated 6,000 
lives a year. This form of cancer also is 
one of the deadliest forms of the disease. 
"Metastatic melanoma is notoriously 
resistant to chemotherapy," says Howard 
K. Koh, M.D., a skin-cancer expert with 
the Hubert H, Humphrey Cancer Research 
Center. Though there is little physicians 
can do once a tumor has spread from the 
skin to other sites, Dr. Koh says much can 
be done to stop the cancer prior to that 
point. He argues that public education, 
combined with the screening of those at 
special risk for melanoma, could have 
(iamatic effects. "I believe that we could 
eliminate the vast majority of deaths from 
melanoma," he says. 
Melanoma is one of three main types of 
-skin cancer. The otherxwo;i3asai-cetlcar-
cinoma and squamous-cell carcinoma, are 
much more common. They tend not to 
spread, however, and are rarely fatal. 
The cells affected by melanoma are the 
ones that change color when we tan. Ironi-
cally, individuals who work too hard on 
their tans—or who inadvertently underes-
timate how much sun they are getting— 
may be putting themselves at risk for the 
disease. 
"The problem doesn't appear to be 
cumulative exposure to the sun," says Dr. 
Koh. "Instead, we think it's severe 
episodes—the kind that produces redness 
and blisters." 
Other factors that may put individuals at 
risk include skin color—melanoma is large-
ly a disease of Caucasians—and a family 
history of the disease. "If your mother, 
father, sister or brother has had melanoma," 
says Dr. Koh, "your chances of being af-
fected are ten times greater than average." 
Despite melanoma's virulence, it readily 
lends itself to preventive efforts. For one 
thing, the tumors can start as pre-cancerous 
skin blemishes. These are often easy to 
identify, and can be removed in a 
physician's office. 
In addition, says Dr. Koh, screening is a 
simple matter of visually examining the 
skin. "There's nothing invasive about skin-
IfitteTharapenttC'Opttong available to 
physicians who treat cancer have ex-
panded markedly over recent decades, one 
thing has not changed: the need to deal 
with the fear, psychic pain and depression 
that are almost inevitable companions to 
the disease. 
Robert M. Beazley, M.D., a surgeon 
and a member of the Hubert H. Humphrey 
Cancer Research Center, says he believes 
the best way for physicians to help patients 
confront these emotions is to be as candid 
as is realistically possible. 
At times—especially when he's giving 
patients the diagnosis they dread hearing— 
that is not easy. "When you tell patients 
they have cancer, it can be like hitting 
them with a brick," he says. 
Yet that kind of candor is vital in nurtur-
cancer screening, as there may be in screen 
ing for other types of cancers," he says. 
The first large-scale screening effort, 
sponsored by the American Academy of 
Dermatology, was launched in 1985 and 
has so far covered about 300,000 in-
dividuals. Dr. Koh says he and other advo-
cates of screening would like to see such 
programs extended to many millions more, 
but notes that one of the obstacles is that 
there is no definitive proof as yet this 
would save lives. "Most of the melanomas 
picked up during screenings are in an early 
phase," he says. "That suggests we're 
reducing mortality rates, but we have to 
have more data in order to document that." 
continued on back 
ing trust, says Dr. Beazley, Who also is 
chief of cancer surgery at the University 
Hospital in Boston. "In the past, there was 
a tendency to believe you shouldn't be 
honest with patients about cancer," he 
says. "My attitude is, 1 have to tell 
patients the truth because if 1 don' t, 
they're going to catch me, and then there 
will be no relationship." 
Being candid in giving a diagnosis, of 
course, is just the first step in building a 
relationship based on trust. Dr. Beazley 
notes that you must walk a fine line, trying 
to be as sympathetic and upbeat as you 
can without raising false hopes. 
"1 tell patients that I don't have all the 
answers," he says, "but that I'll continue to 
continued on back 
Surgeon sees candor and a willingness 
to listen as vital in helping patients cope 
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What you can do to check for melanoma 
Should you be doing anything about melanoma? 
Yes you should, says Dr. Koh—especially if you're in a high-risk group for the 
disease. You're in that group if you: 
• have had one or more episodes of very severe sunburn; 
• have an unusually large number of moles for your age; or 
• have a close relative who has had meUmoma. 
You can check for melanoma growths or their pre-cancerous predecessors on 
your own or with the help of a family member. The growths typically appear on 
the back or legs. They look somewhat like moles, but have irregular shapes, arc 
usually multi-colored, and are often elevated above skin level. 
If you find such a blemish, says Dr. Koh, you should ask about having it check-
ed by either your family physician or a dermatologist. But even if you have no 
suspect areas on your skin, you may still want to be screened. It is a a very simple 
and short procedure, says Dr. Koh. You can check with your local medical 
society to see if free, public screenings are held in your area, or ask your doctor 
about getting screened. 
Skin cancer 
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With Cancer Center associates. Dr. 
Koh is working to develop evidence that 
screening is an effective way to cut 
melanoma's toll. He is not waiting for the 
outcome of these efforts, though, to 
promote the technique. 
A 1988 winner of a National Cancer In-
stitute Preventive Oncology Academic 
Award, he has been working hard to en-
courage screenings in Massachusetts. 
Recently, Dr. Koh has won a key role in 
CANCER NOTE: Most cancer cases in 
the United States are believed to be en-
vironmentally related; in other words, 
they are associated in some way with our 
physical surroundings, personal habits or 
lifestyles. Occupational hazards, although 
associated with only a small percentage of 
cancers, are under close surveillance. 
Virtually every suspected major chemical 
and other substance in the workplace 
presumed to be a health risk is under in-
vestigation. Each study can require years 
and hundreds of thousands of dollars to 
complete. 
CANCER NOTE: There are hazards for 
nonsmokers who breathe the smoke of 
others' cigarettes. Several scientific 
studies, including a recent study by the 
American Cancer Society, have found an 
national and international efforts as well, 
becoming chairman of the Academy of 
Dermatology's Committee on 
Melanoma/Skin Cancer Screening and a 
member of the World Health 
Organization's Committee on Melanoma. 
Dr. Koh is convinced that pushing 
ahead with mass screenings makes sense. 
"I think we're going to have definitive 
answers about screening's effectiveness in 
the next five to ten years," he says, "but I 
see no need to wait because, intuitively, 
screening makes a tremendous amount of 
sense." 
increased risk of lung cancer among non-
smoking wives of cigarette smokers. Al-
though some studies have not shown an ef-
fect, evidence continues to grow indicat-
ing that involuntary smoking is a hazard. 
CANCER NOTE: Interferons, a group 
of natural body proteins, were originally 
discovered as antiviral agents, and later 
were found to have some anticancer ac-
tivity as well. Interferons now are being 
used successfully in the treatment of hairy 
cell leukemia, and patients with certain 
forms of lymphomas and papillomas have 
response rates approaching 90 percent. 
More temporary responses also may be 
seen in kidney cancer, Kaposi's sarcoma, 
melanoma and chronic myelogenous 
leukemia. 
Willingness to listen 
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be honest with them. I also try to see each 
one of my patients every day, seven days a 
week, while they're in the hospital. I sit 
down next to them, and talk with them." 
Often, patients will ask him questions 
they already have put to him several times: 
about their chances, about when their pain 
will subside, about whether their cancer 
has spread. 
This isn't because cancer patients are 
unusually forgetful, says Dr. Beazley. 
"They're testing you," he explains. 
"They're trying to find out if you're telling 
them everything you know. Then, once 
they decide you've told them the whole 
story, a rapport is established, and they 
start to realize that you're probably their 
best advocate." 
Reaching that point, of course, is just 
the start in terms of helping patients come 
to terms with their illness. Even after suc-
cessful treatment, says Dr. Beazley, tough 
hurdles lie ahead for many patients. 
The time immediately after discharge, 
when the extensive support patients 
receive in the hospital is replaced by what 
is usually a far lesser degree of attention, 
can be especially difficult, he says. It is 
also common for patients who face an ex-
tended period of wondering whether their 
tumors will re-appear to face numerous 
spells of depression. 
Dr. Beazley's approach, even for those 
individuals whose outlook is cloudy at 
best, is to encourage hopefulness. "I think 
that if you have a positive attitude, no mat-
ter what your prognosis, you're going to 
do better than if you're in a depressed 
state," he says, adding, "and I know a lot 
of that starts with the physician." 
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